Hong Kong, China vs Latvia: Tuberculosis patients living with HIV receiving antiretroviral therapy

Hong Kong, China
27 patients
in 2021
Latvia
35 patients
in 2017
Hong Kong, China rank
96th
Latvia rank
93rd

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Hong Kong, China
  • Latvia
0204060200320122021

How they compare

Latvia currently reports 35 patients against 27 patients in Hong Kong, China, a difference of 8 patients.

That makes Latvia's figure about 1.3 times Hong Kong, China's.

Across all 9 years both countries report, Latvia has been ahead every year.

Hong Kong, China ranks 96th and Latvia ranks 93rd of 183 countries.

Latvia has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Hong Kong, China Latvia Difference Ahead
2000s 17.4 patients 32 patients 14.6 patients Latvia
2010s 7.75 patients 42.5 patients 34.75 patients Latvia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Hong Kong, China or Latvia?
Latvia, at 35 patients against 27 patients in Hong Kong, China as of 2017.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Hong Kong, China and Latvia?
8 patients, with Latvia ahead.
How many years of comparable data are there for Hong Kong, China and Latvia?
9 years are reported by both, from 2005 to 2017.
How do Hong Kong, China and Latvia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Hong Kong, China ranks 96th and Latvia ranks 93rd of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Hong Kong, China vs Latvia: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 16 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/hong-kong-sar-china/latvia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/hong-kong-sar-china/latvia/">Hong Kong, China vs Latvia: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.